ALVEOLAR SOFT PART SARCOMA
Clinical trials for ALVEOLAR SOFT PART SARCOMA explained in plain language.
Never miss a new study
Get alerted when new ALVEOLAR SOFT PART SARCOMA trials appear
Sign up with your email to follow new studies for ALVEOLAR SOFT PART SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Last-Resort cell therapy targets rare cancer in single patient
Disease control OngoingThis study tests a made-to-order cell therapy called GCAR1 in one person with advanced alveolar soft part sarcoma that has spread and has no standard treatments left. The therapy uses the patient's own immune cells, modified to recognize and attack cancer cells that carry a prote…
Matched conditions: ALVEOLAR SOFT PART SARCOMA
Phase: EARLY_PHASE1 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated May 17, 2026 01:48 UTC
-
New hope for kids with rare cancers: drug blocks tumor growth
Disease control OngoingThis study tests a drug called cabozantinib in children and young adults (up to age 30) with rare cancers like sarcomas, Wilms tumor, and others that have come back or not responded to standard therapy. The drug works by blocking enzymes that help tumors grow and form blood vesse…
Matched conditions: ALVEOLAR SOFT PART SARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:58 UTC
-
New combo therapy aims to shrink sarcomas before surgery
Disease control OngoingThis study looks at whether adding the drug pazopanib to standard radiation or chemoradiation helps shrink soft tissue sarcomas before they are removed surgically. About 140 adults and children with newly diagnosed, high-risk sarcomas that can be operated on are participating. Th…
Matched conditions: ALVEOLAR SOFT PART SARCOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 16:02 UTC